Skip to content

Public FDA record

Z-2432-2026: Medline convenience kits: C-SECTION KIT DYNJ904305J C-SECTION PACK DYNJ69533C

Recall record Z-2432-2026 for Medline Industries, LP. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2432-2026
Company in FDA record
Medline Industries, LP
FDA classification date
Jun 12, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Kits contain recalled lot of Ferndale Laboratories MASTISOL Liquid Adhesive. Butyrate tubing may crack during actuation and render product unusable for application.

Source facts

Action
Firm began notifying consignees on 4/27/2026. Customers were instructed to request stickers to over-label affected convenience kits with a warning label. Warning label indicates for user to remove the affected component and replace it with product from supply. No kits are to be returned.
Initiated
2026-04-27
Root cause
Process control
Distribution
US Nationwide distribution. OUS distribution pending.
Recall number
Z-2432-2026
Recall status
Open, Classified
CDRH record ID
220435
FDA classified
2026-06-12
Recall event number
98951

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗